Michael Scolaro

Michael Scolaro

Sep 01, 2017

Group 6 Copy 130
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Wormfree World - Finding New Cures

    Hookworms affect the lives of more than 400,000,000 men, women and children around the world. The most effective...

    Viral Causes of Lung Cancer

    We have special access to blood specimens collected from more than 9,000 cancer free people. These individuals...

    Developing A New Treatment For Neurodegenerative Diseases

    1 in 3 people over the age of 65 will die with Alzheimer's disease or some other form of dementia. Current...

    Backer Badge Funded